Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

NK cells play a role in skin diseases like eczema and psoriasis.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

New genetic discoveries may lead to better treatments for alopecia areata.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Developing human skin has immune cells with memory-like features.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

FOXN1 mutations cause severe immunodeficiency, hair loss, nail issues, and thymus defects.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Clonally expanded CD8+ T cells cause alopecia areata.